The measurement of nicotinamide adenine dinucleotide (NAD) levels in human peripheral blood mononuclear cells has been realized at the Miraikai Medical Corporation/Tokyo Ginza Wellness & Aging Clinic.

By measuring NAD, a marker of ageing, before and after taking nicotinamide mononucleotide (NMN), it is possible to know the amount of NAD in the body and its changes, and the degree of progression of ageing. and can be used for daily health management.

Click here to see the press release.